scholarly journals Interpreting the interfacial and colloidal stability of bulk nanobubbles

Soft Matter ◽  
2018 ◽  
Vol 14 (47) ◽  
pp. 9643-9656 ◽  
Author(s):  
N. Nirmalkar ◽  
A. W. Pacek ◽  
M. Barigou

This paper elucidates parts of the mystery behind the interfacial and colloidal stability of the novel bubble system of bulk nanobubbles.

Foods ◽  
2020 ◽  
Vol 9 (9) ◽  
pp. 1228
Author(s):  
Alessio Cimini ◽  
Mauro Moresi

In large-sized breweries, rough beer clarification is still carried out using Kieselguhr filters notwithstanding their environmental and safety implications. The main aim of this work was to test an innovative rough beer clarification and stabilization process involving enzymatic treating with Brewers Clarex®, centrifuging, rough filtering across 1.4-μm ceramic hollow-fiber membrane at 30 °C, and fine filtering through 0.45-μm cartridge filter. When feeding an enzymatically-pretreated and centrifuged rough beer with permanent haze (HP) of 2 or 14 European Brewery Convention unit (EBC-U), its primary clarification under periodic CO2 backflushing yielded a permeate with turbidity of 1.0–1.5 EBC-U at a high permeation flux (2.173 ± 51 or 593 ± 100 L m−2 h−1), much greater than that typical of powder filters. The final beer was brilliant (HP = 0.57 ± 0.08 EBC-U) with almost the same colloidal stability of the industrial control and an overall log reduction value (~5.0 for the selected beer spoilage bacterium or 7.6 for the brewing yeast) in line with the microbial effectiveness of current sterilizing membranes. It was perceived as significantly different in flavor and body from the industrial control at a probability level of 10% by a triangle sensory test, as more likely related to the several lab-scale beer-racking steps used than to the novel process itself.


Author(s):  
Ol’ga A. Poddubnaya

The development of the novel approaches to the enhancement of the effectiveness of the rehabilitative measures for the patients presenting with chronic cholecystitis in the combination with opistorchosis and dysfunction of the urinary bladder remains a serious challenge. The timely comprehensive non-medicamentous rehabilitation with the application of the chronobiologcal methods may be instrumental in the normalization of the functional state of the biliary system and the improvement of the characteristics of colloidal stability of bile with the simultaneous promotion of the adaptive capacities of the organism. Such rehabilitation is likely to increase the therapeutic effectiveness of the rehabilitative measures and reduce the risk of the progress of the disease and the development of complications.


Pharmaceutics ◽  
2019 ◽  
Vol 11 (5) ◽  
pp. 246 ◽  
Author(s):  
Juan I. Bussio ◽  
Carla Molina-Perea ◽  
José Vicente González-Aramundiz

Vaccination faces many challenges nowadays, and among them the use of adjuvant molecules and needle-free administration are some of the most demanding. The combination of transcutaneous vaccination and nanomedicine through a rationally designed new-formulation could be the solution to this problem. This study focuses on this rational design. For this purpose, new hyaluronic acid nanocapsules (HA-NCs) have been developed. This new formulation has an oily nucleus with immunoadjuvant properties (due to α tocopherol) and a shell made of hyaluronic acid (HA) and decorated with ovalbumin (OVA) as the model antigen. The resulting nanocapsules are smaller than 100 nm, have a negative superficial charge and have a population that is homogeneously distributed. The systems show high colloidal stability in storage and physiological conditions and high OVA association without losing their integrity. The elevated interaction of the novel formulation with the immune system was demonstrated through complement activation and macrophage viability studies. Ex vivo studies using a pig skin model show the ability of these novel nanocapsules to penetrate and retain OVA in higher quantities in skin when compared to this antigen in the control solution. Due to these findings, HA-NCs are an interesting platform for needle-free vaccination.


2010 ◽  
Vol 34 (8) ◽  
pp. S33-S33
Author(s):  
Wenchao Ou ◽  
Haifeng Chen ◽  
Yun Zhong ◽  
Benrong Liu ◽  
Keji Chen

Sign in / Sign up

Export Citation Format

Share Document